Myroides odoratus and Chryseobacterium indologenes: Two rare isolates in the immunocompromised

Indian Journal of Medical Microbiology

Volumn 32, Issue 3, 2014, Pages 327-330

  Deepa, R ^a   Venkatesh, K G ^a   Parveen, J Durdana ^a   Banu, S Thasneem ^a   Jayalakshmi, G ^a  

^a MADRAS MEDICAL COLLEGE   (India)

Author keywords

Chryseobacterium indologenes; minimum inhibitory concentration; myroides odoratus

Indexed keywords

AMIKACIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; ORAL ANTIDIABETIC AGENT; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TOBRAMYCIN; TUBERCULOSTATIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE REPORT; CHRYSEOBACTERIUM INDOLOGENES; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; FLAVOBACTERIACEAE; FLAVOBACTERIACEAE INFECTION; HUMAN; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MYROIDES ODORATUS; NONHUMAN; CHRYSEOBACTERIUM; DRUG EFFECTS; FLAVOBACTERIACEAE INFECTIONS; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOLOGY;

ANTI-BACTERIAL AGENTS; CHRYSEOBACTERIUM; FEMALE; FLAVOBACTERIACEAE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 84905669584     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.136592     Document Type: Article

References (10)

1. Vancanneyt M, Segers P, Torck U, Hoste B, Bernardet JF, Vandamme P, et al. Reclassification of Flavobacterium odoratum (Stutzer 1929) Strains to a new genus, myroides, as myroides odoratus comb. nov. and myroides odoratimimus sp. nov. Inter J Syst Bacteriol 1996;46:926-32.
2. In: Winn WC Jr, Koneman EW, Allen SD, Procop GW, Janda WM, Schreckenberger PC, editors. The Nonfermentative Gram - Negative Bacilli. Koneman's Colour Atlas and Textbook of Diagnostic Microbiology. Ch 7., 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 304-91.
3. Holmes B, Snell JJ, Lapage SP. Flavobacterium odoratum: A species resistant to a wide range of antimicrobial agents. J Clin Pathol 1979;32:73-7.
4. CLSI. Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. CLSI document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
5. Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997;41:2738-41.
6. Benedetti P, Rassu M, Pavan G, Sefton A, Pellizzer G. Septic shock, pneumonia, and soft tissue infection due to Myroides odoratimimus: Report of a case and review of Myroides infections. Infection 2011;39:161-5.
7. Hsueh PR, Hsiue TR, Wu JJ, Teng LJ, Ho SW, Hsieh WC, et al. Flavobacterium indologenes bacteremia: Clinical and microbiological characteristics. Clin Infect Dis 1996;23:550-5.
8. Bhuyar G, Jain S, Shah H, Mehta VK. Urinary tract infection by Chryseobacterium indologenes. Indian J Med Microbiol 2012;30:370-2.
9. Sudharani V, Asiya, Saxena NK. Chryseobacterium indologenes bacteremia in a preterm baby. Indian J Med Microbiol 2011;29:196-8.
10. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004;42:445-8.